Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 420 publications
The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence.
Journal: Expert review of anticancer therapy
Published: July 17, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD-negative acute myeloid leukemia.
Journal: Future oncology (London, England)
Published: July 11, 2026
The PRIME trial: An investigator-initiated, multicentre, phase II study of the poly(ADP-ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)-mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromes.
Journal: British journal of haematology
Published: July 02, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
Overall survival and long-term outcomes from the randomized, double-blind, placebo-controlled, phase III IMerge trial of imetelstat for lower-risk myelodysplastic syndromes.
Journal: Haematologica
Published: June 22, 2026
Beyond the Catalogue: Design and Biological Enrichment as the Next Priorities in Higher-Risk MDS Drug Development.
Journal: European journal of haematology
Published: June 07, 2026
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.
Journal: The New England journal of medicine
Published: June 03, 2026
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.
Journal: NEJM evidence
Published: May 26, 2026
Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia.
Journal: Blood. Red cells & iron
Published: May 04, 2026
Last Updated: 09/26/2026